Top1000 Scholar

Scholarly Index

Sara A. Hurvitz

The University of Texas MD Anderson Cancer Center; 30,479 total citations; 523 total publications; best world rank #6

The University of Texas MD Anderson Cancer Center

30,479Total citations
523Total publications
76H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Cancer Treatment and PharmacologyLifetime142US 7899.55
Advanced Breast Cancer TherapiesLifetime55US 2499.48
HER2/EGFR in Cancer ResearchLifetime121US 6299.45
Monoclonal and Polyclonal Antibodies ResearchLifetime403US 24199.26
Breast Cancer Treatment StudiesLifetime251US 13099.16
Peptidase Inhibition and AnalysisLifetime519US 23798.17
PI3K/AKT/mTOR signaling in cancerLifetime238US 14497.91
PARP inhibition in cancer therapyLifetime205US 10597.21
Brain Metastases and TreatmentLifetime387US 22497.41
Chronic Lymphocytic Leukemia ResearchLifetime955US 44197.77
BRCA gene mutations in cancerLifetime931US 48194.83
Advanced Breast Cancer Therapies2021-20256US 499.90
Breast Cancer Treatment Studies2021-202511US 499.83
Cancer Treatment and Pharmacology2021-20258US 599.87
HER2/EGFR in Cancer Research2021-20258US 499.88
Monoclonal and Polyclonal Antibodies Research2021-202524US 999.34
Cancer-related Molecular Pathways2021-202523US 1298.18
Brain Metastases and Treatment2021-202597US 5596.35
Protein Degradation and Inhibitors2021-2025184US 9095.94
Lung Cancer Research Studies2021-2025564US 17693.67
Peptidase Inhibition and Analysis2021-2025563US 13790.59
Radiopharmaceutical Chemistry and Applications2021-2025975US 23985.05
Cancer-related cognitive impairment studies2021-2025326US 14381.86
Neutropenia and Cancer Infections2021-2025719US 24372.09
Cancer, Stress, Anesthesia, and Immune Response2021-2025903US 22557.53